2186 related articles for article (PubMed ID: 33711707)
1. The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19.
Schönfelder K; Breuckmann K; Elsner C; Dittmer U; Fistera D; Herbstreit F; Risse J; Schmidt K; Sutharsan S; Taube C; Jöckel KH; Siffert W; Kribben A; Möhlendick B
Cytokine; 2021 Jun; 142():155492. PubMed ID: 33711707
[TBL] [Abstract][Full Text] [Related]
2. Impact of interferon-induced transmembrane protein 3 gene rs12252 polymorphism on COVID-19 mortality.
Ahmadi I; Afifipour A; Sakhaee F; Zamani MS; Mirzaei Gheinari F; Anvari E; Fateh A
Cytokine; 2022 Sep; 157():155957. PubMed ID: 35792282
[TBL] [Abstract][Full Text] [Related]
3. Interferon-Induced Transmembrane Protein-3 Rs12252-G Variant Increases COVID-19 Mortality Potential in Egyptian Population.
Elessawy SM; Shehab A; Soliman DA; Eldeeb MA; Taha SI
Viral Immunol; 2024 May; 37(4):186-193. PubMed ID: 38717821
[TBL] [Abstract][Full Text] [Related]
4. The significance of IFITM3 polymorphism in COVID-19 asymptomatic and ICU admission Kurdish patients.
Rashid PMA; Salih GF
Cytokine; 2023 Nov; 171():156349. PubMed ID: 37683443
[TBL] [Abstract][Full Text] [Related]
5. IFITM3 Inhibits SARS-CoV-2 Infection and Is Associated with COVID-19 Susceptibility.
Xu F; Wang G; Zhao F; Huang Y; Fan Z; Mei S; Xie Y; Wei L; Hu Y; Wang C; Cen S; Liang C; Ren L; Guo F; Wang J
Viruses; 2022 Nov; 14(11):. PubMed ID: 36423162
[TBL] [Abstract][Full Text] [Related]
6. Ethnic variation in risk genotypes based on single nucleotide polymorphisms (SNPs) of the interferon-inducible transmembrane 3 (IFITM3) gene, a susceptibility factor for pandemic 2009 H1N1 influenza A virus.
Kim YC; Jeong BH
Immunogenetics; 2020 Dec; 72(9-10):447-453. PubMed ID: 33174121
[TBL] [Abstract][Full Text] [Related]
7. Population genetics of IFITM3 in Portugal and Central Africa reveals a potential modifier of influenza severity.
David S; Correia V; Antunes L; Faria R; Ferrão J; Faustino P; Nunes B; Maltez F; Lavinha J; Rebelo de Andrade H
Immunogenetics; 2018 Mar; 70(3):169-177. PubMed ID: 28842783
[TBL] [Abstract][Full Text] [Related]
8. Association between the interferon-induced transmembrane protein 3 gene (
Cuesta-Llavona E; Albaiceta GM; García-Clemente M; Duarte-Herrera ID; Amado-Rodríguez L; Hermida-Valverde T; Enríquez-Rodriguez AI; Hernández-González C; Melón S; Alvarez-Argüelles ME; Boga JA; Rojo-Alba S; Vázquez-Coto D; Gómez J; Coto E
Curr Res Virol Sci; 2021; 2():100016. PubMed ID: 34870250
[TBL] [Abstract][Full Text] [Related]
9. TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco.
Benmansour R; Tagajdid MR; El Hamzaoui H; Fjouji S; Doghmi N; Houba A; Belbacha I; Elkochri S; Aabi R; Elannaz H; Laraqui A; El Mchichi B; Chmitah T; Touil N; Ennibi K; Eljaoudi R; Elmir E; Amine Lahlou I; Oumzil H
Int J Immunopathol Pharmacol; 2024; 38():3946320241257241. PubMed ID: 38760017
[TBL] [Abstract][Full Text] [Related]
10. Interferon-induced transmembrane protein 3 gene polymorphisms are associated with COVID-19 susceptibility and severity: A meta-analysis.
Li Y; Wei L; He L; Sun J; Liu N
J Infect; 2022 Jun; 84(6):825-833. PubMed ID: 35461906
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 and TNFα genes associated with susceptibility and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
Pecoraro V; Cuccorese M; Trenti T
Clin Exp Med; 2023 Nov; 23(7):3251-3264. PubMed ID: 37055652
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphism between the Sorani and Hawrami kurdish populations and COVID-19 outcome.
Rashid PMA; Salih GF
Mol Biol Rep; 2023 Jun; 50(6):5177-5183. PubMed ID: 37119412
[TBL] [Abstract][Full Text] [Related]
13. IFITM3 rs12252 polymorphism association with COVID-19 severity and mortality in a Brazilian sample: an update and a meta-analysis.
Araújo JLF; Bonifácio VF; Batista LM; Ávila RE; Aguiar RS; Bastos-Rodrigues L; Souza RP
An Acad Bras Cienc; 2024; 96(2):e20231160. PubMed ID: 38808879
[TBL] [Abstract][Full Text] [Related]
14. Interferon-Induced Transmembrane Protein 3 rs34481144 C/T Genotype and Clinical Parameters Related to Progression of COVID-19.
Gholami M; Sakhaee F; Mirzaei Gheinari F; Sotoodehnejadnematalahi F; Ghazanfari Jajin M; Zamani MS; Ahmadi I; Anvari E; Fateh A
J Immunol Res; 2023; 2023():2345062. PubMed ID: 37323564
[TBL] [Abstract][Full Text] [Related]
15. Strong Correlation between the Case Fatality Rate of COVID-19 and the rs6598045 Single Nucleotide Polymorphism (SNP) of the Interferon-Induced Transmembrane Protein 3 (
Kim YC; Jeong BH
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33396837
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of IFITM3 rs12252 Association With Severe Pediatric Influenza Infection.
Randolph AG; Yip WK; Allen EK; Rosenberger CM; Agan AA; Ash SA; Zhang Y; Bhangale TR; Finkelstein D; Cvijanovich NZ; Mourani PM; Hall MW; Su HC; Thomas PG; ;
J Infect Dis; 2017 Jul; 216(1):14-21. PubMed ID: 28531322
[TBL] [Abstract][Full Text] [Related]
17. SNP-mediated disruption of CTCF binding at the IFITM3 promoter is associated with risk of severe influenza in humans.
Allen EK; Randolph AG; Bhangale T; Dogra P; Ohlson M; Oshansky CM; Zamora AE; Shannon JP; Finkelstein D; Dressen A; DeVincenzo J; Caniza M; Youngblood B; Rosenberger CM; Thomas PG
Nat Med; 2017 Aug; 23(8):975-983. PubMed ID: 28714988
[TBL] [Abstract][Full Text] [Related]
18. Interferon-induced transmembrane protein-3 genetic variant rs12252 is associated with COVID-19 mortality.
Alghamdi J; Alaamery M; Barhoumi T; Rashid M; Alajmi H; Aljasser N; Alhendi Y; Alkhalaf H; Alqahtani H; Algablan O; Alshaya AI; Tashkandi N; Massadeh S; Almuzzaini B; Ehaideb SN; Bosaeed M; Ayoub K; Yezli S; Khan A; Alaskar A; Bouchama A
Genomics; 2021 Jul; 113(4):1733-1741. PubMed ID: 33838280
[TBL] [Abstract][Full Text] [Related]
19. The frequency of combined IFITM3 haplotype involving the reference alleles of both rs12252 and rs34481144 is in line with COVID-19 standardized mortality ratio of ethnic groups in England.
Nikoloudis D; Kountouras D; Hiona A
PeerJ; 2020; 8():e10402. PubMed ID: 33240681
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Human
Martins JSC; Oliveira MLA; Garcia CC; Siqueira MM; Matos AR
Front Cell Infect Microbiol; 2020; 10():352. PubMed ID: 32754450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
